MeixiaoLongMD

Physician

Dr. Long is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
460 W 10th Ave
Columbus, OH 43210
Phone+1 614-293-8858

Fax+1 614-293-7484

Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2013 - 2016
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2010 - 2013
China Medical University ShenyangClass of 1996

PubMed

1 citations
Acute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Bijal Shah, Ryan J Mattison, Ramzi Abboud, Peter Abdelmessieh, Ibrahim Aldoss
Journal of the National Comprehensive Cancer Network. 2024-10-01
Siglec-6 as a therapeutic target for cell migration and adhesion in chronic lymphocytic leukemia.
Jessica Nunes, Rakeb Tafesse, Charlene Mao, Matthew Purcell, Xiaokui Mo
Nature Communications. 2024-06-18
Repression of PRMT activities sensitize homologous recombination-proficient ovarian and breast cancer cells to PARP inhibitor treatment.
Youyou Zhang, Mu Xu, Jiao Yuan, Zhongyi Hu, Junjie Jiang
Biorxiv. 2024-05-21

Abstracts/Posters

Phase 1 First-in-Human Trial of AMV564, a Bivalent Bispecific (2:2) CD33/CD3 T-Cell Engager, in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)Clinicall...
Meixiao Long, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Γδ T Cells for Immunotherapy
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019